Minnesota SF 168: Excessive price increases by manufacturers prohibition to generic or off-patent drugs

Status: Comm report: To pass as amended and re-refer to Judiciary and Public Safety (as of 2023-03-27)

State: Minnesota · Session: 2023-2024 · Bill: SF 168

Subjects: Consumer Protection, Drugs and Medicine

Sponsors: Morrison, Boldon, Fateh, Hoffman, Mann

View Minnesota SF 168 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.